Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Quviviq
Pharma
Idorsia eyes pediatric insomnia market with ph. 2 win
After a phase 2 trial win, Idorsia’s insomnia med Quviviq is one step closer to potentially becoming a first-in-class treatment for children.
Zoey Becker
Mar 30, 2026 11:25am
Idorsia shares sink after CEO's abrupt departure
Mar 16, 2026 11:00am
Idorsia's insomnia drug enters clinic as a treatment for PTSD
May 10, 2023 9:00am
Idorsia requests to de-schedule DORA insomnia drugs
Apr 7, 2023 10:55am
Intra-Cellular winner of the Fierce Madness Drug Ad Tournament
Mar 22, 2023 8:30am
Idorsia sleep survey will keep you up at night
Dec 1, 2022 9:15am
